Cornerstone Therapeutics receives Warning Letter from FDA regarding labels
On its website, the FDA posted a Warning Letter sent to Cornerstone Therapeutics CEO Craig A. Collard regarding labels that "lack approved applications." Reference Link :theflyonthewall.com
News For CRTX From The Last 14 Days
Check below for free stories on CRTX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
